ガイドライン Guideline

疾患/病態 とガイドライン

リウマチ性疾患に対する中等量ー高用量ステロイド(EULAR EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
副腎不全患者に対する周術期ステロイドカバー(Association of Anaesthetists Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency
人工股関節・膝関節全置換術における抗リウマチ薬の周術期マネージメント(ACR 2022 American College of Rheumatology/American Association of Hip and Knee Surgeions guideline on the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty
リウマチ性疾患の周産期マネージメント(ACR 2020 American College of Rheumatolgy guideline for the management of reproductive health in rheumatic and musculoskeltal diseases
妊娠と授乳中の抗リウマチ薬とステロイド(BSR BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids
妊娠と授乳中の鎮痛薬、その他(BSR BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice
罹患女性患者の妊娠、出産を考えた治療指針(厚生労働省 難治性疾患克服研究事業「関節リウマチ(RA)や炎症性腸疾患(IBD)罹患女性患者の妊娠、出産を考えた治療指針の作成」研究班 全身性エリテマトーデス(SLE)、関節リウマチ(RA)、若年性特発性関節炎(JIA)や炎症性腸疾患(IBD) 罹患女性患者の妊娠、出産を考えた治療指針
COVID-19パンデミック下のリウマチ性疾患を有する成人患者マネージメント(ACR American College of Rheumatology guidance for the management of rheumatic diseases in adult patients during the COVD-19 pandemic; version 3
COVID-19パンデミック下のリウマチ性疾患を有する小児患者マネージメント(ACR American College of Rheumatology guidance for the management of pediatric rheumatic diseases during the COVD-19 pandemic; version 2